Abstract:Background In current years, the CRISPR (clustered regularly interspaced short palindromic repeats) based strategies have emerged as the most promising molecular tool in the field of gene editing, intracellular imaging, transcriptional regulation and biosensing. However, the recent CRISPR-based diagnostic technologies still require the incorporation of other amplification strategies (such as polymerase chain reaction) to improve the cis/trans cleavage activity of Cas12a, which complicates the detection workflow and lack of a uniform compatible system to respond to the target in one pot. Results To better fully-functioning CRISPR/Cas12a, we reported a novel technique for straightforward nucleic acid detection by incorporating enzyme-responsive steric hindrance-based branched inhibitors with CRISPR/AsCas12a methodology. The construction-transferable branched inhibitors coupled with a specific overhang flap induce spatial steric effects and result in the loss of the binding ability of Cas12a, which inhibits the activity of Cas12a. Target as the input signal would trigger the site-directed APE1 enzyme incision of the inhibitors, thus transforming the conformation of the inhibitors into split activators to illumine the CRISPR/AsCas12a catalyst system. At the same time, we found that APE1 could drive the enzymatic positive feedback circuit and exhibited considerably high amplification efficiency to enhance the detection ability of nucleic acids. Besides, our method provides universal platforms and can be realized in real-time and one-pot detection of HIV-1 DNA by replacing the inhibitors and crRNA with different target recognition sequences. Significance and Novelty Overall, due to the high programmability of the nucleic acid network, this work proposed a feasible way to use the steric hindrance-based inhibitors as a switchable element, decorating the CRISPR/Cas12a-based strategy equipment for molecular diagnostics. Besides, this strategy could offer a simple tool for detecting trace nucleic acid, which opens avenues for future clinical application.

Introducing structure-switching functionality into small-molecule-binding aptamers via nuclease-directed truncation.

No Structure-Switching Required: A Generalizable Exonuclease-Mediated Aptamer-Based Assay for Small-Molecule Detection

Using dual exonucleases to finely distinguish structural adjustment of aptamers for small-molecule detection

Engineering G-quadruplex aptamer to modulate its binding specificity

Structure-based investigation of a DNA aptamer targeting PTK7 reveals an intricate 3D fold guiding functional optimization

Development of folding-based and signal-amplified fluorescence aptasensors using G-quadruplex quinclorac aptamer variants engineered via exonuclease digestion and circular dichroism spectroscopy

Truncations and in silico Docking to Enhance the Analytical Response of Aptamer-Based Biosensors

Sensitive Chemiluminescence Aptasensor Based on Exonuclease-Assisted Recycling Amplification.

Label-free profiling of DNA aptamer-small molecule binding using T5 exonuclease

Multi-Scaled Explorations of Binding-Induced Folding of Intrinsically Disordered Protein Inhibitor IA3 to Its Target Enzyme

Interrogating aptamer chemical space through modified nucleotide substitution facilitated by enzymatic DNA synthesis

A massively parallel screening platform for converting aptamers into molecular switches

Switching the activity of Taq polymerase using clamp-like triplex aptamer structure

Splitting aptamers and nucleic acid enzymes for the development of advanced biosensors

Engineering smart thioflavin T binders with switchable DNA topologies for constructing multiple label-free biosensors

Molecular Engineering of Aptamer Self-Assemblies Increases in Vivo Stability and Targeted Recognition

In vitro isolation of small-molecule-binding aptamers with intrinsic dye-displacement functionality

Highly Sensitive Electrochemical Aptasensor Based on A Ligase-Assisted Exonuclease Iii-Catalyzed Degradation Reaction

Unconventional Split Aptamers Cleaved at Functionally Essential Sites Preserve Biorecognition Capability.

Structure-switchable branched inhibitors regulate the activity of CRISPR-Cas12a for nucleic acid diagnostics

Aptamer-involved fluorescence amplification strategy facilitated by directional enzymatic hydrolysis for bioassays based on a metal-organic framework platform: Highly selective and sensitive determination of thrombin and oxytetracycline